CLINICAL_TRIALS
trial_result
· 2013-07-31
Clinical Trial Update: A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease [Phase 2]
Summary
Phase 2 study evaluating the safety and efficacy of ustekinumab (CNTO 1275) in Crohn's disease has completed, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centocor, Inc. | Conditions: Crohn Disease | Phase 2 | Status: COMPLETED | Results posted: 2013-07-31